Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gliadel

EISAI

Eisai opens first office in Australia

New Melbourne base to support marketing of Halaven and Fycompa

EISAI

Eisai “speechless” as G-BA denies price premium for Fycompa

But company has better news on cancer drug Halaven

- PMLiVE

Astellas EMEA CEO volunteers at school

Ken Jones promotes healthy lifestyle as part of Changing Tomorrow campaign

- PMLiVE

Astellas earmarks up to $1.2bn for protein folding research

Teams up with US company to investigate diseases caused by protein defects

Bayer symbol

Bayer completes takeover of Chinese OTC company

Expands consumer health presence with Dihon purchase

- PMLiVE

Takeda launches mobile app for heartburn patients

Food4GERD app includes symptom tracker and ingredient check functions

Bayer symbol

Bayer CEO Dekkers points to ‘outstanding’ pharma growth

On target to meet company’s annual expectations of €7.5bn

- PMLiVE

US judge cuts billions from Takeda/Lilly Actos payment

Court rules that companies must now pay damages of $36.8m rather than $9bn

- PMLiVE

Eisai backs competition to find star of epilepsy comic book

Teams up with Medikidz to educate young people about the condition

- PMLiVE

Bayer’s Xarelto wins another NICE recommendation

Deemed cost-effective use of NHS resources to prevent blood clots following a heart attack

- PMLiVE

Takeda’s obesity drug Contrave launches in US

Clears cardiovascular safety hurdle to be third new weight-loss drug in recent months

- PMLiVE

Eisai launches online breast cancer resource

Website includes information on the disease, treatment options and side effects

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links